Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-61,000
Closed -$2.99M 47
2025
Q2
$2.99M Buy
61,000
+17,000
+39% +$951K 0.29% 40
2025
Q1
$2.49M Hold
44,000
0.29% 40
2024
Q4
$2.53M Sell
44,000
-136,000
-76% -$7.75M 0.28% 40
2024
Q3
$9.43M Sell
180,000
-352,000
-66% -$18.3M 1.07% 34
2024
Q2
$28.8M Sell
532,000
-41,000
-7% -$2.24M 3.46% 10
2024
Q1
$33.2M Buy
573,000
+81,500
+17% +$4.19M 3.52% 11
2023
Q4
$24.1M Buy
491,500
+24,750
+5% +$1.17M 2.74% 14
2023
Q3
$20.1M Buy
466,750
+20,750
+5% +$922K 2.55% 16
2023
Q2
$20.3M Hold
446,000
2.49% 17
2023
Q1
$16.8M Sell
446,000
-11,800
-3% -$401K 2.08% 25
2022
Q4
$13.9M Buy
+457,800
New +$13.7M 1.77% 29

Other funds holding CPRT

Harvey Partners's CPRT Position: Q3 2025 in Review

Harvey Partners sold out of Copart (CPRT) in Q3 2025, closing a stake of 61,000 shares — an estimated $2.99M sold.

Harvey Partners first reported a position in CPRT in Q4 2022 and held it in 11 quarters. The position peaked at $33.2M in Q1 2024. 1,145 funds tracked by Wall St. Rank hold CPRT as of Q3 2025.

  • Harvey Partners reported no remaining Copart position as of Q3 2025 after selling out during the quarter.
  • Harvey Partners sold 61,000 Copart shares in Q3 2025, an estimated $2.99M.
  • Harvey Partners first reported a position in Copart in Q4 2022 and held it in 11 quarters.
  • Harvey Partners's Copart position peaked at $33.2M in Q1 2024.
  • 1,145 funds tracked by Wall St. Rank held Copart as of Q3 2025.

Based on Harvey Partners's 13F filing for Q3 2025, filed 14 Nov 2025.